Potential of ceragenin CSA-13 and its mixture with pluronic F-127 as treatment of topical bacterial infections

Journal of Applied Microbiology

Volumn 110, Issue 1, 2011, Pages 229-238

  Leszczynska K ^a   Namiot, A ^a   Cruz, K ^b   Byfield, F J ^b   Won, E ^b   Mendez, G ^b   Sokolowski W ^b   Savage, P B ^c   Bucki, R ^b   Janmey, P A ^b  

^a MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c Brigham Young University   (United States)

Author keywords

Antibacterial agents; Microbiological assay; Pluronic F 127

Indexed keywords

BACTERIA; BLOOD; CEREBROSPINAL FLUID; MOLECULES; PEPTIDES;

AMPHIPHILIC MORPHOLOGY; ANTI-BACTERIAL ACTIVITY; ANTIBACTERIAL PEPTIDES; BACTERIAL INFECTIONS; BACTERIAL KILLING; CATIONICS; CHOLIC ACIDS; HEMOLYTIC ACTIVITY; MICROBIOLOGICAL ASSAYS; PLURONIC F-127;

ASSAYS;

CATHELICIDIN ANTIMICROBIAL PEPTIDE LL 37; CERAGENIN CSA 13; LACTOFERRIN; LYSOZYME; POLOXAMER; POLYPEPTIDE ANTIBIOTIC AGENT; SECRETORY PHOSPHOLIPASE A2; UNCLASSIFIED DRUG;

ANTIBIOTIC RESISTANCE; ANTIMICROBIAL ACTIVITY; BACTERIAL DISEASE; BACTERIUM; BIOASSAY; BIOFILM; BLOOD; CONCENTRATION (COMPOSITION); DISEASE TREATMENT; EXPERIMENTAL STUDY; INHIBITOR; PEPTIDE; POLYMER;

ANTIBACTERIAL ACTIVITY; ARTICLE; ASCITES; BACTERIAL INFECTION; BACTERIAL STRAIN; BACTERICIDAL ACTIVITY; BIOFILM; CEREBROSPINAL FLUID; DRUG BLOOD LEVEL; HEMOLYSIS; HUMAN; IN VITRO STUDY; LUNG FIBROSIS; LUNG LAVAGE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MINIMUM INHIBITORY CONCENTRATION; PSEUDOMONAS AERUGINOSA; SALIVA; STAPHYLOCOCCUS AUREUS;

BACTERIA (MICROORGANISMS); PSEUDOMONAS AERUGINOSA; STAPHYLOCOCCUS AUREUS;

EID: 78650142775     PISSN: 13645072     EISSN: 13652672     Source Type: Journal    
DOI: 10.1111/j.1365-2672.2010.04874.x     Document Type: Article

References (47)

1. Barichello, J.M., Morishita, M., Takayama, K. and Nagai, T. (1999) Absorption of insulin from pluronic F-127 gels following subcutaneous administration in rats. Int J Pharm 184, 189-198.
2. Bartoszewicz, M., Rygiel, A., Krzeminski, M. and Przondo-Mordarska, A. (2007) Penetration of a selected antibiotic and antiseptic into a biofilm formed on orthopedic steel implants. Ortop Traumatol Rehabil 9, 310-318.
3. Bucki, R. and Janmey, P.A. (2006) Interaction of the gelsolin-derived antibacterial PBP10 peptide with lipid bilayers and cell membranes. Antimicrob Agents Chemother 50, 2932-2940.
4. Bucki, R., Pastore, J.J., Randhawa, P., Vegners, R., Weiner, D.J. and Janmey, P.A. (2004) Antibacterial activities of rhodamine B-conjugated gelsolin-derived peptides compared to those of the antimicrobial peptides cathelicidin LL37, magainin II, and melittin. Antimicrob Agents Chemother 48, 1526-1533.
5. Bucki, R., Byfield, F.J. and Janmey, P.A. (2007a) Release of the antimicrobial peptide LL-37 from DNA/F-actin bundles in cystic fibrosis sputum. Eur Respir J 29, 624-632.
6. Bucki, R., Sostarecz, A.G., Byfield, F.J., Savage, P.B. and Janmey, P.A. (2007b) Resistance of the antibacterial agent ceragenin CSA-13 to inactivation by DNA or F-actin and its activity in cystic fibrosis sputum. J Antimicrob Chemother 60, 535-545.
7. Bucki, R., Namiot, D.B., Namiot, Z., Savage, P.B. and Janmey, P.A. (2008) Salivary mucins inhibit antibacterial activity of the cathelicidin-derived LL-37 peptide but not the cationic steroid CSA-13. J Antimicrob Chemother 62, 329-335.
8. Cai, X., Cao, Y.L., Cui, L., Liu, W. and Guan, W.X. (2005) Use of autologous tissue engineered skin to treat porcine full-thickness skin defects. Chin J Traumatol 8, 269-276.
9. Chin, J.N., Rybak, M.J., Cheung, C.M. and Savage, P.B. (2007) Antimicrobial activities of ceragenins against clinical isolates of resistant Staphylococcus aureus. Antimicrob Agents Chemother 51, 1268-1273.
10. Chin, J.N., Jones, R.N., Sader, H.S., Savage, P.B. and Rybak, M.J. (2008) Potential synergy activity of the novel ceragenin, CSA-13, against clinical isolates of Pseudomonas aeruginosa, including multidrug-resistant P. aeruginosa. J Antimicrob Chemother 61, 365-370.
11. Ciornei, C.D., Sigurdardottir, T., Schmidtchen, A. and Bodelsson, M. (2005) Antimicrobial and chemoattractant activity, lipopolysaccharide neutralization, cytotoxicity, and inhibition by serum of analogs of human cathelicidin LL-37. Antimicrob Agents Chemother 49, 2845-2850.
12. Ding, B., Guan, Q., Walsh, J.P., Boswell, J.S., Winter, T.W., Winter, E.S., Boyd, S.S., Li, C. et al. (2002) Correlation of the antibacterial activities of cationic peptide antibiotics and cationic steroid antibiotics. J Med Chem 45, 663-669.
13. Epand, R.M., Epand, R.F. and Savage, P.B. (2008) Ceragenins (cationic steroid compounds), a novel class of antimicrobial agents. Drug News Perspect 21, 307-311.
14. Escobar-Chavez, J.J., Lopez-Cervantes, M., Naik, A., Kalia, Y.N., Quintanar-Guerrero, D. and Ganem-Quintanar, A. (2006) Applications of thermo-reversible pluronic F-127 gels in pharmaceutical formulations. J Pharm Pharm Sci 9, 339-358.
15. Fiebelkorn, K.R., Crawford, S.A., McElmeel, M.L. and Jorgensen, J.H. (2003) Practical disk diffusion method for detection of inducible clindamycin resistance in Staphylococcus aureus and coagulase-negative staphylococci. J Clin Microbiol 41, 4740-4744.
16. Gilligan, P.H. (1991) Microbiology of airway disease in patients with cystic fibrosis. Clin Microbiol Rev 4, 35-51.
17. Gould, I.M., MacKenzie, F.M., MacLennan, G., Pacitti, D., Watson, E.J. and Noble, D.W. (2007) Topical antimicrobials in combination with admission screening and barrier precautions to control endemic methicillin-resistant Staphylococcus aureus in an Intensive Care Unit. Int J Antimicrob Agents 29, 536-543.
18. Herasimenka, Y., Benincasa, M., Mattiuzzo, M., Cescutti, P., Gennaro, R. and Rizzo, R. (2005) Interaction of antimicrobial peptides with bacterial polysaccharides from lung pathogens. Peptides 26, 1127-1132.
19. Howell, M.D., Streib, J.E., Kim, B.E., Lesley, L.J., Dunlap, A.P., Geng, D., Feng, Y., Savage, P.B. et al. (2009) Ceragenins: a class of antiviral compounds to treat orthopox infections. J Invest Dermatol 129, 2668-2675.
20. Isogai, E., Isogai, H., Takahashi, K., Okumura, K. and Savage, P.B. (2009) Ceragenin CSA-13 exhibits antimicrobial activity against cariogenic and periodontopathic bacteria. Oral Microbiol Immunol 24, 170-172.
21. Kadurugamuwa, J.L., Sin, L., Albert, E., Yu, J., Francis, K., DeBoer, M., Rubin, M., Bellinger-Kawahara, C. et al. (2003) Direct continuous method for monitoring biofilm infection in a mouse model. Infect Immun 71, 882-890.
22. Kichler, A., Leborgne, C., Savage, P.B. and Danos, O. (2005) Cationic steroid antibiotics demonstrate DNA delivery properties. J Control Release 107, 174-182.
23. Kristiansen, J.E. (1992) The antimicrobial activity of non-antibiotics. Report from a congress on the antimicrobial effect of drugs other than antibiotics on bacteria, viruses, protozoa, and other organisms. APMIS Suppl 30, 7-14.
24. Lai, X.Z., Feng, Y., Pollard, J., Chin, J.N., Rybak, M.J., Bucki, R., Epand, R.F., Epand, R.M. et al. (2008) Ceragenins: cholic acid-based mimics of antimicrobial peptides. Acc Chem Res 41, 1233-1240.
25. Lara, D., Feng, Y., Bader, J., Savage, P. and Maldonado, R. (2010) Anti-trypanosomatid activity of ceragenins. J Parasitol, 96, 638-642.
26. Lee, S.H., Lee, J.E., Baek, W.Y. and Lim, J.O. (2004) Regional delivery of vancomycin using pluronic F-127 to inhibit methicillin resistant Staphylococcus aureus (MRSA) growth in chronic otitis media in vitro and in vivo. J Control Release 96, 1-7.
27. Leszczynska, K., Namiot, A., Fein, D.E., Wen, Q., Namiot, Z., Savage, P.B., Diamond, S., Janmey, P.A. et al. (2009) Bactericidal activities of the cationic steroid CSA-13 and the cathelicidin peptide LL-37 against Helicobacter pylori in simulated gastric juice. BMC Microbiol 9, 187.
28. Li, C., Lewis, M.R., Gilbert, A.B., Noel, M.D., Scoville, D.H., Allman, G.W. and Savage, P.B. (1999) Antimicrobial activities of amine- and guanidine-functionalized cholic acid derivatives. Antimicrob Agents Chemother 43, 1347-1349.
29. Lindahl, M., Faris, A., Wadstrom, T. and Hjerten, S. (1981) A new test based on 'salting out' to measure relative surface hydrophobicity of bacterial cells. Biochim Biophys Acta 677, 471-476.
30. Lynch, A.S. and Robertson, G.T. (2008) Bacterial and fungal biofilm infections. Annu Rev Med 59, 415-428.
31. Mainz, J.G., Naehrlich, L., Schien, M., Kading, M., Schiller, I., Mayr, S., Schneider, G., Wiedemann, B. et al. (2009) Concordant genotype of upper and lower airways P. aeruginosa and S. aureus isolates in cystic fibrosis. Thorax 64, 535-540.
32. Malabarba, A., Ciabatti, R., Kettenring, J., Scotti, R., Candiani, G., Pallanza, R., Berti, M. and Goldstein, B.P. (1992) Synthesis and antibacterial activity of a series of basic amides of teicoplanin and deglucoteicoplanin with polyamines. J Med Chem 35, 4054-4060.
33. Maruyama, I., Hasegawa, T., Yamamoto, T. and Momose, K. (1989) Effects of pluronic F-127 on loading of fura 2/AM into single smooth muscle cells isolated from guinea pig taenia coli. J Toxicol Sci 14, 153-163.
34. Nagant, C., Tré-Hardy, M., El-Ouaaliti, M., Savage, P., Devleeschouwer, M. and Dehaye, J.P. (2010) Interaction between tobramycin and CSA-13 on clinical isolates of Pseudomonas aeruginosa in a model of young and mature biofilms. Appl Microbiol Biotechnol 88, 251-263.
35. Norden, C.W. (1982) Problems in determination of antibiotic synergism in vitro. Rev Infect Dis 4, 276-281.
36. Patel, P.P., Vasquez, S.A., Granick, M.S. and Rhee, S.T. (2008) Topical antimicrobials in pediatric burn wound management. J Craniofac Surg 19, 913-922.
37. Peeters, E., Nelis, H.J. and Coenye, T. (2008) Comparison of multiple methods for quantification of microbial biofilms grown in microtiter plates. J Microbiol Methods 72, 157-165.
38. Perry, E.L., Beck, J.P., Williams, D.L. and Bloebaum, R.D. (2009) Assessing peri-implant tissue infection prevention in a percutaneous model. J Biomed Mater Res B Appl Biomater 92, 397-408.
39. Rahbar, M., Mehrgan, H. and Hadji-Nejad, S. (2010) Enhancement of vancomycin activity by phenothiazines against vancomycin-resistant Enterococcus faecium in vitro. Basic Clin Pharmacol Toxicol 107, 676-679.
40. Randazzo, R.A., Bucki, R., Janmey, P.A. and Diamond, S.L. (2009) A series of cationic sterol lipids with gene transfer and bactericidal activity. Bioorg Med Chem 17, 3257-3265.
41. Saha, S., Savage, P.B. and Bal, M. (2008) Enhancement of the efficacy of erythromycin in multiple antibiotic-resistant gram-negative bacterial pathogens. J Appl Microbiol 105, 822-828.
42. Singh, P.K., Tack, B.F., McCray, P.B. Jr and Welsh, M.J. (2000) Synergistic and additive killing by antimicrobial factors found in human airway surface liquid. Am J Physiol Lung Cell Mol Physiol 279, L799-L805.
43. Standards CLSI (2009) Performance Standards for Antimicrobial Susceptibility Testing; Nineteenth Informational Supplement. Clinical and Laboratory Standards Institute 29, M-100-S119.
44. Tang, J.X., Wen, Q., Bennett, A., Kim, B., Sheils, C.A., Bucki, R. and Janmey, P.A. (2005) Anionic poly(amino acid)s dissolve F-actin and DNA bundles, enhance DNase activity, and reduce the viscosity of cystic fibrosis sputum. Am J Physiol Lung Cell Mol Physiol 289, L599-L605.
45. Van Bambeke, F., Mingeot-Leclercq, M.P., Struelens, M.J. and Tulkens, P.M. (2008) The bacterial envelope as a target for novel anti-MRSA antibiotics. Trends Pharmacol Sci 29, 124-134.
46. Wang, Y., Agerberth, B., Lothgren, A., Almstedt, A. and Johansson, J. (1998) Apolipoprotein A-I binds and inhibits the human antibacterial/cytotoxic peptide LL-37. J Biol Chem 273, 33115-33118.
47. Weiner, D.J., Bucki, R. and Janmey, P.A. (2003) The antimicrobial activity of the cathelicidin LL37 is inhibited by F-actin bundles and restored by gelsolin. Am J Respir Cell Mol Biol 28, 738-745.